You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 105 No. 2, February 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (35)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Results and Prognostic Factors in Vitrectomy for Diabetic Vitreous Hemorrhage

John T. Thompson, MD; Serge de Bustros, MD; Ronald G. Michels, MD; Thomas A. Rice, MD

Arch Ophthalmol. 1987;105(2):191-195.


Abstract

• The final visual acuities and prognostic factors predictive of these results were analyzed in 353 eyes that had pars plana vitrectomy for nonclearing diabetic vitreous hemorrhage. Eighty-one percent of the eyes had improved visual acuities on final examination. The percentage of eyes that achieved a visual acuity of 20/100 or better and the percentage that achieved 5/200 or better increased during the study period. Preoperative factors associated with a favorable visual prognosis included the following: (1) preoperative visual acuity of 5/200 or better, (2) absence of iris neovascularization, (3) absence of neovascular glaucoma, (4) clear lens or minimal cataract, and (5) panretinal photocoagulation of at least one fourth of the fundus. Intraoperative factors associated with a favorable visual prognosis included retaining the crystalline lens and absence of an intraocular gas bubble.



Author Affiliations

From the Department of Ophthalmology and Visual Science, Yale University, New Haven, Conn (Dr Thompson); the Wilmer Ophthalmological Institute, The Johns Hopkins University, Baltimore (Drs de Bustros and Michels); and the Department of Ophthalmology, Case Western Reserve University, Cleveland (Dr Rice).


Footnotes

Accepted for publication Sept 12, 1986.

Reprint requests to Maumenee 127, 600 N Wolfe St, Baltimore, MD 21205 (Dr Michels).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction
French et al.
BMJ 1996;312:1637-1641.
ABSTRACT | FULL TEXT  

Thrombolysis in patients with diabetes
Newman et al.
BMJ 1995;310:1008a-1008.
FULL TEXT  

Reoperation Following Diabetic Vitrectomy
Brown et al.
Arch Ophthalmol 1992;110:506-510.
ABSTRACT  

Results and Prognostic Factors in Vitrectomy for Diabetic Traction-Rhegmatogenous Retinal Detachment
Thompson et al.
Arch Ophthalmol 1987;105:503-507.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.